Readmission Following Inpatient Stereotactic Radiosurgery for Brain Tumors

Overview

Journal J Radiosurg SBRT

Date 2019 Oct 24

PMID 31641547

Authors

Austin M Tang

Joshua Bakhsheshian

Michelle Lin

Casey A Jarvis

Edith Yuan

Ian A Buchanan

Li Ding

Ben A Strickland

Eric Chang

Gabriel Zada

William J Mack

Frank J Attenello

Affiliations

Soon will be listed here.

Abstract

Background: Stereotactic radiosurgery (SRS) is indicated for a spectrum of brain tumors and is often an outpatient procedure, though severe disease may precipitate inpatient treatment. Readmission following inpatient SRS for brain tumors is not well understood.

Objectives: To characterize rate, associative factors, and predictors of SRS readmission.

Methods: Retrospective analysis of inpatients treated with SRS for brain neoplasms was conducted (2010-2014 Nationwide Readmissions Database). Diagnoses upon readmission were characterized. Associations with 30-day readmission were identified using multivariate analyses.

Results: Of 2,553 patients undergoing SRS, 390 were readmitted (15.3%) within 30 days. Leading readmission diagnoses were infectious or embolic. Neurological readmissions of intracerebral hemorrhage (2.1%) and cerebral edema (1.5%) were rare. Malignant tumors (OR=1.60, p=0.007) and discharge to facility (OR=1.41, p=0.004) were associated with readmission.

Conclusion: Inpatients receiving SRS for brain tumors have a 15.3% 30-day readmission rate. Neurologic readmissions were rare, underscoring the neurological safety of SRS, even in sick inpatients.

References

McClelland 3rd S, Jalai C, Ryu S, Passias P . Limitations of using population-based databases to assess trends in spinal stereotactic radiosurgery. J Radiosurg SBRT. 2018; 4(3):177-180. PMC: 5658800. View

Shrieve D, Alexander 3rd E, Wen P, Fine H, Kooy H, Black P . Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme. Neurosurgery. 1995; 36(2):275-82; discussion 282-4. DOI: 10.1227/00006123-199502000-00006. View

Lieu A, Hwang S, Howng S, Chai C . Brain tumors with hemorrhage. J Formos Med Assoc. 1999; 98(5):365-7. View

Frischer J, Fraller A, Mallouhi A, Vogl U, Baier F, Ertl A . Evaluation of Dose-Staged Gamma Knife Radiosurgical Treatment Method for High-Risk Brain Metastases. World Neurosurg. 2016; 94:352-359. DOI: 10.1016/j.wneu.2016.07.038. View

Milano M, Sharma M, Soltys S, Sahgal A, Usuki K, Saenz J . Radiation-Induced Edema After Single-Fraction or Multifraction Stereotactic Radiosurgery for Meningioma: A Critical Review. Int J Radiat Oncol Biol Phys. 2018; 101(2):344-357. DOI: 10.1016/j.ijrobp.2018.03.026. View

Cabrera A, Cuneo K, Desjardins A, Sampson J, McSherry F, Herndon 2nd J . Concurrent stereotactic radiosurgery and bevacizumab in recurrent malignant gliomas: a prospective trial. Int J Radiat Oncol Biol Phys. 2013; 86(5):873-9. DOI: 10.1016/j.ijrobp.2013.04.029. View

Tamariz L, Harkins T, Nair V . A systematic review of validated methods for identifying ventricular arrhythmias using administrative and claims data. Pharmacoepidemiol Drug Saf. 2012; 21 Suppl 1:148-53. DOI: 10.1002/pds.2340. View

Glantz M, Cole B, Forsyth P, Recht L, Wen P, Chamberlain M . Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000; 54(10):1886-93. DOI: 10.1212/wnl.54.10.1886. View

Yamanaka K, Iwai Y, Shuto T, Kida Y, Sato M, Hayashi M . Treatment Results of Gamma Knife Radiosurgery for Central Neurocytoma: Report of a Japanese Multi-Institutional Cooperative Study. World Neurosurg. 2016; 90:300-305. DOI: 10.1016/j.wneu.2016.03.016. View

10.

Farnia B, Voong K, Brown P, Allen P, Guha-Thakurta N, Prabhu S . Stereotactic radiosurgery for intraventricular brain metastases. J Neurosurg. 2014; 121 Suppl:26-34. DOI: 10.3171/2014.8.GKS141354. View

11.

Woodworth G, Baird C, Garces-Ambrossi G, Tonascia J, Tamargo R . Inaccuracy of the administrative database: comparative analysis of two databases for the diagnosis and treatment of intracranial aneurysms. Neurosurgery. 2009; 65(2):251-6. DOI: 10.1227/01.NEU.0000347003.35690.7A. View

12.

Donoho D, Wen T, Babadjouni R, Schwartzman W, Buchanan I, Cen S . Predictors of 30- and 90-day readmission following craniotomy for malignant brain tumors: analysis of nationwide data. J Neurooncol. 2017; 136(1):87-94. PMC: 7441072. DOI: 10.1007/s11060-017-2625-3. View

13.

Al-Dorzi H, Alruwaita A, Marae B, Alraddadi B, Tamim H, Ferayan A . Incidence, risk factors and outcomes of seizures occurring after craniotomy for primary brain tumor resection. Neurosciences (Riyadh). 2017; 22(2):107-113. PMC: 5726815. DOI: 10.17712/nsj.2017.2.20160570. View

14.

Hansasuta A, Choi C, Gibbs I, Soltys S, Tse V, Lieberson R . Multisession stereotactic radiosurgery for vestibular schwannomas: single-institution experience with 383 cases. Neurosurgery. 2011; 69(6):1200-9. DOI: 10.1227/NEU.0b013e318222e451. View

15.

Akl E, Kahale L, Agoritsas T, Brignardello-Petersen R, Busse J, Carrasco-Labra A . Handling trial participants with missing outcome data when conducting a meta-analysis: a systematic survey of proposed approaches. Syst Rev. 2015; 4:98. PMC: 4511978. DOI: 10.1186/s13643-015-0083-6. View

16.

Marcus L, McCutcheon B, Noorbakhsh A, Parina R, Gonda D, Chen C . Incidence and predictors of 30-day readmission for patients discharged home after craniotomy for malignant supratentorial tumors in California (1995-2010). J Neurosurg. 2014; 120(5):1201-11. DOI: 10.3171/2014.1.JNS131264. View

17.

Ansari S, Yan H, Zou J, Worth R, Barbaro N . Hospital Length of Stay and Readmission Rate for Neurosurgical Patients. Neurosurgery. 2017; 82(2):173-181. DOI: 10.1093/neuros/nyx160. View

18.

Zafar S, Shah A, Channa H, Raoof M, Wilson L, Wasif N . Comparison of Rates and Outcomes of Readmission to Index vs Nonindex Hospitals After Major Cancer Surgery. JAMA Surg. 2018; 153(8):719-727. PMC: 6142950. DOI: 10.1001/jamasurg.2018.0380. View

19.

Szekendi M, Williams M, Carrier D, Hensley L, Thomas S, Cerese J . The characteristics of patients frequently admitted to academic medical centers in the United States. J Hosp Med. 2015; 10(9):563-8. PMC: 5032986. DOI: 10.1002/jhm.2375. View

20.

Stummer W . Mechanisms of tumor-related brain edema. Neurosurg Focus. 2007; 22(5):E8. DOI: 10.3171/foc.2007.22.5.9. View